Alumni

	Laura Wozniak, M.D. ICPTP Trainee, Second Year Fellow Division of Pediatric Gastroenterology, Hepatology, and Nutrition Department of Pediatrics David Geffen School of Medicine at UCLA 10833 Le Conte Ave, Rm 22-315 Los Angeles, CA 90095-1693 LWozniak@mednet.ucla.edu Laura Wozniak received her medical degree from the Albert Einstein College of Medicine in the Bronx, New York. She then completed her Pediatric residency at UCLA. Laura is currently fellow in Pediatric Gastroenterology, Hepatology, and Nutrition. Clinically, she is invested in caring for liver and small bowel transplant patients. Her primary research interest is the identification of biomarkers of tolerance after liver transplantation, with the ultimate goal of enabling clinicians to individualize immunosuppression in transplant recipients.
	David E. Piccioni, M.D., Ph.D. ICPTP Trainee, Second Year Clinical Instructor UCLA Neuro-Oncology Program David Geffen School of Medicine at UCLA 710 Westwood Plaza, Suite 1230 RNRC Los Angeles, CA 90095 dpiccioni@mednet.ucla.edu David Piccioni graduated from the State University of New York at Buffalo with a combined M.D., Ph.D. degree, with a focus in neuroscience. He then completed a Neurology residency at UCLA. David is currently a Neuro-Oncology fellow at UCLA. His primary research interest is the development of chemotherapy resistance in glioblastoma, and ways to overcome and avoid these mechanisms of resistance, with a goal of establishing individualized tumor analysis and customized chemotherapy.
	Loida Viera, M.D. ICPTP Trainee, Second Year Fellow Division of Allergy and Clinical Immunology Department of Pediatrics David Geffen School of Medicine at UCLA 10833 LeConte Ave, MDCC 12-430 Los Angeles, CA. 90095 lviera@mednet.ucla.edu Loida Viera received her M.D. from Tulane Medical School in 2004. She completed her Internal Medicine training at Yale New-Haven Hospital affiliated with Yale University School of Medicine in 2007. Loida is currently a fellow in Allergy and Clinical Immunology at UCLA. Her present research goal is to elucidate the interaction between a severe asthma promoting polymorphism and asthma-promoting oxidative stress pathways as illustrative of gene/gene and gene/environment interactions that are fundamental to disease pathogenesis. Her long-term objective is to devise novel therapeutic strategies to combat asthma morbidity and mortality.
	William A. Freije, M.D., Ph.D. Assistant Professor Department of Obstetrics and Gynecology David Geffen School of Medicine at UCLA 200 Medical Plaza, Suite 430 Los Angeles, CA 90095 wfreije@mednet.ucla.edu William A. Freije, M.D., Ph.D. is an Assistant Professor in the Department of Obstetrics and Gynecology. He received his M.D. from Tufts University in 1991, and completed his residency at Los Angeles County/ University of Southern California, and his Fellowship in Reproductive Endocrinology at the University of Texas, Southwestern Medical Center. Dr. Freije joined the Division of Reproductive Endocrinology here at UCLA in 1999. Subsequently he completed his Ph.D. in Human Genetics in 2005, at which time he was appointed Assistant Professor. His research has focused on genomic evaluation through high throughput experiments based upon microarrays. His graduate work focused on expression profiling of glioblastoma and other human brain tumors. His recent research has employed RNA interference to evaluate the mitochondrial regulation of cell cycle control, and guided experiments evaluating toll signaling in the innate immune response of Drosophila. His research interests include pre-implantation genetic diagnosis, genomic evaluation, epigenetic regulation, and cell cycle control/cancer biology.
	Jimmy Brown, DDS, MD, FACS Department of Otolaryngology Stanford University Medical Center Jimmy Brown earned a dental degree from Howard University in 1983, followed by a medical degree from George Washington University in 1988. After residency training in head and neck surgery in 1993, he served in the United States Army as a commissioned officer, where he rose to the rank of Major. He completed a fellowship in advanced head and neck oncological surgery at Stanford University in 1996. Dr. Brown is a Clinical Associate Professor in the Department of Otolaryngology at Stanford.
	Carla Janzen, MD, PhD Department of Obstetrics and Gynecology David Geffen School of Medicine at UCLA Carla Janzen obtained her medical degree at Dartmouth-Brown University School of Medicine, completed her residency training in obstetrics and gynecology at UCLA, and is a graduate student of the PhD program in UCLA's Department of Molecular and Medical Pharmacology. She is receiving training in clinical pharmacology to understand pharmacokinetic changes during pregnancy. Dr. Janzen's future goals include training in maternal-fetal medicine and conducting clinical research in the role of sex steroids in inducing or inhibiting the activity of the hepatic cytochrome P450 enzymes and metabolism.
	Rodney McKeever, MD, FCCP Critical Care Medicine, Transfusion Medicine Department of Anesthesiology Martin Luther King/Harbor Medical Center Rodney McKeever graduated from Southern Illinois University School of Medicine and completed his anesthesiology residency at Charles Drew University, after which he enhanced his knowledge base with further training in critical care medicine at UC Irvine and in transfusion medicine at UCLA. He is Assistant Professor of Anesthesiology at Martin Luther King/Harbor Medical Center. Dr. McKeever's research focuses on the pharmacokinetics of nutraceuticals and their effects on the bioavailibility of analgesic and anesthetic agents. Through his research mentor Dr. David Heber, Dr. McKeever received an appointment as Assistant Researcher at the Center for Human Nutrition at UCLA.
	Robert Venick, MD Division of Gastroenterology, Hepatology and Nutrition Department of Pediatrics David Geffen School of Medicine at UCLA Robert Venick graduated from Duke University and received his medical degree from the University of Southern California. He is an Assistant Professor in Pediatric Gastroenterology, Hepatoloty, and Nutrition Program at the Mattel Children's Hospital at UCLA. Dr. Venick is interested in clinical research in hepatology, liver and intestinal transplatation. During his training he pursued a Master of Science in Clinical Research through UCLA’s K30 program. A Glaser Pediatric Research Network Clinical Investigator Fellow, Dr. Venick collaborated with pediatric colleagues at multiple academic centers in research ranging from post-transplant autoimmune hepatitis to nutrition following stem cell transplantation. His research focuses on the relationship of drug-related gene polymorphisms to immunosuppression and patient outcomes in pediatric liver transplantation.
	James Farrell, MD Division of Digestive Diseases Department of Medicine David Geffen School of Medicine at UCLA Box 951693, 200 Med Plaza Suite 365A Los Angeles, CA 90095-1693 jfarrell@mednet.ucla.edu After graduating from medical school from the University College Dublin, Ireland, James Farrell completed his residency training in internal medicine at the Johns Hopkins Hospital and fellowship training in gastroenterology and advanced therapeutic endoscopy at Massachusetts General Hospital, the Brigham and Women’s Hospital, and Harvard Medical School. He is a faculty member in the Division of Digestive Diseases at UCLA and director of the Endoscopic Ultrasound Program, with a special interest in gastrointestinal oncology. Dr. Farrell's translational research is focused on the pharmacogenomics of gastrointestinal cancer therapy, early detection of pancreatic cancer, pancreatic cystic neoplasms, and endoscopic delivery of gene therapy for the treatment of pancreatic cancer.
	Marc Riedl, MD Division of Clinical Immunology and Allergy Department of Medicine David Geffen School of Medicine at UCLA Box 951680, 52-175 CHS Los Angeles, CA 90095-1680 mriedl@mednet.ucla.edu Marc Riedl received his medical degree from the University of Chicago-Pritzker School of Medicine, completed a residency in internal medicine at Barnes-Jewish Hospital of Washington University in St. Louis, and a fellowship in clinical immunology and allergy at UCLA. Dr. Riedl also received a Master Degree in Clinical Research through UCLA's K30 Program. His professional interests include the development of novel therapeutics for the treatment of allergic and immunodeficient conditions. His research is in the study of compounds to reduce the inflammatory effects of air pollution and methods of immune tolerance induction for allergy prevention. Dr. Riedl is also integrally involved in phase I to III development of several investigational and orphan drugs.
	Sherilyn Gordon Burroughs, MD Division of Liver and Pancreas Transplant Department of Surgery David Geffen School of Medicine at UCLA Box 957054, 77-120 CHS Los Angeles, CA 90095-7054 sgordon@mednet.ucla.edu Sherilyn Gordon Burroughs received her medical degree from Washington University in St. Louis, completed general surgery training at Howard University and a transplant immunology research fellowship at the University of Pittsburgh Thomas E. Starzl Transplant Institute. Subsequently, she completed a clinical multi-visceral transplant surgery fellowship at the UCLA-Dumont Transplant Center. Dr. Burroughs is a faculty member in the Division of Liver and Pancreas Transplant. Her research is focused on the regulation and reversal of drug resistance in hepatocellular carcinoma. Her current interests involve intestinal transplantation and tolerance.
	Anil Sharma, MD, MBA Semel Institute for Neuroscience & Human Behavior David Geffen School of Medicine at UCLA C8-244 Semel Los Angeles, CA 90095 asharma@mednet.ucla.edu After graduating from University of Rajasthan S.M.S. Medical College in India, Anil Sharma completed residency training in psychiatry at UNMC/Creighton University School of Medicine and worked at the Palo Alto VA/Stanford University School of Medicine. Dr. Sharma joined UCLA in June 2005 as a fellow in the Interdepartmental Clinical Pharmacology Training Program (ICPTP) and as Associate Director of Pharmacogenomics and Pharmacogenetics Group. Funded by the NIH, his research projects focused on the pharmacogenomics and pharmacogenetics of antidepressant medications, and effects of human leptin. Dr. Sharma is a faculty member in the Department of Psychiatry and Behavioral Sciences. His research involves the study of polymorphisms in central nicotinic acetylcholine receptors and their effects on cognition, schizophrenia and dementia.
	Roger S. Lo, MD, PhD Division of Dermatology Department of Medicine David Geffen School of Medicine at UCLA Box 956957, 200 Med Plaza Suite 450 Los Angeles, CA 90095-6957 rlo@mednet.ucla.edu Roger Lo graduated from Stanford University where he did undergraduate research on mammalian membrane transporters and virology. He then trained at the Cornell/Sloan-Kettering/Rockefeller Tri-institutional M.D.-Ph.D. Program in Manhattan where he embarked on cancer research with Dr. Joan Massagué (HHMI). After completing a dermatology residency at UCLA, he performed post-doctoral research with Owen Witte (HHMI) and is now transitioning to head a laboratory, which focuses on melanoma tumor biology, genetics, and therapy. He currently holds a Career Award for Medical Scientists from the Burrough’s Wellcome Fund and directs the Melanoma Clinic in Dermatology at UCLA.

Not logged in |
Log In |

Contact Us :: PPRG :: Clinical Pharmacology Program :: GCRC :: UCLA :: UCLA Schedule of Classes :: UCLA Extension :: URSA Online